Essential Feasibility Metrics for Selecting the Right Clinical Trial Sites

Choosing the right investigational sites is one of the most critical factors influencing the success of a clinical trial. Site feasibility assessments go beyond basic questionnaires—they require evaluating robust metrics that predict a site’s ability to deliver high-quality data, recruit effectively, and meet regulatory standards. This guide explores key feasibility metrics sponsors and CROs should use to select optimal clinical trial sites.

Why Metrics Matter in Site Feasibility

Traditional site selection methods often rely on subjective impressions or past relationships. However, with rising regulatory expectations and protocol complexity, data-driven site selection is now essential. Metrics offer:

• Quantifiable insight into site capabilities
• Better forecasting for patient enrollment
• Improved operational planning
• Reduced risk of non-compliance or delays

Resources such as StabilityStudies.in offer best practices for site documentation and trial integrity.

Top Feasibility Metrics to Evaluate Trial Sites

1. Historical Patient Recruitment Performance

• Number of patients enrolled in previous trials in the same indication
• Speed of enrollment compared to target timelines
• Drop-out and screen failure rates

2. Study Start-Up Timelines

• Average time for Ethics Committee (EC) approval
• Contract finalization time with the sponsor/CRO
• Site initiation visit (SIV) readiness time

3. Regulatory and Audit History

• Number of audits in the last 5 years
• Findings and CAPA responses, if applicable
• Compliance with GMP audit checklist and ICH-GCP standards

4. Therapeutic Area Experience

• Number of trials conducted in the relevant indication
• Specific expertise of principal investigator (PI)
• Availability of trained sub-investigators and coordinators

5. Site Infrastructure Readiness

• Availability of diagnostic tools, labs, and investigational pharmacies
• Functionality of EDC systems and internet bandwidth
• Facilities for IP storage, sample shipment, and patient comfort

Scoring and Ranking Feasibility Metrics

To effectively use metrics, develop a scoring matrix that assigns weights to each criterion based on study priorities. For example:

• Patient Recruitment History: 35%
• Startup Timelines: 25%
• PI and Staff Experience: 15%
• Infrastructure Readiness: 15%
• Audit/Compliance History: 10%

Sites are scored and ranked. Sites below a threshold may be excluded or flagged for risk mitigation.

Digital Tools to Track and Analyze Metrics

• Clinical Trial Management Systems (CTMS)
• Feasibility dashboards within eTMF platforms
• Excel feasibility scoring templates
• CRA report-based feasibility validations

These tools help gather and compare site data across global networks efficiently.

Integrating KPIs into Site Selection SOPs

Use internal Pharma SOP guidelines to standardize feasibility evaluations across studies. SOPs should define:

• What data should be requested
• How metrics are scored and interpreted
• Who is responsible for final site approval

Having consistent feasibility practices improves quality and regulatory inspection readiness.

Regulatory Expectations and Documentation

According to USFDA and EMA, site selection must be justified with documented feasibility assessments. Sponsors must ensure that the process is auditable and that decisions are supported by objective data.

Challenges and Mitigation Strategies

• Incomplete Data from Sites: Encourage sites to provide performance metrics in feasibility questionnaires.
• Overestimated Recruitment: Cross-check against therapeutic benchmarks or past enrollment logs.
• Resource Constraints: Consider central site services or additional monitoring resources.

Conclusion

Feasibility metrics offer a strategic advantage in selecting high-performing clinical trial sites. By using a structured, metrics-driven approach to feasibility, sponsors can reduce risk, optimize enrollment, and ensure quality and compliance throughout the study lifecycle. Effective site selection starts with objective data, not guesswork.

How to Build a Targeted Patient Recruitment Strategy from Site Feasibility

One of the most common causes of clinical trial delays is the failure to meet patient enrollment targets. A well-executed recruitment strategy, rooted in site feasibility insights, significantly enhances a trial’s success. Sponsors and CROs must analyze feasibility data to predict recruitment potential and design targeted strategies for each site. This article outlines how to build an effective patient recruitment strategy based on site feasibility assessments.

Why Site Feasibility Is the Foundation of Recruitment

Site feasibility studies are preliminary evaluations conducted before trial initiation to assess a site’s capacity to conduct the study. They provide critical information on:

• Patient population availability
• Investigator experience and interest
• Site infrastructure and resources
• Past performance in similar protocols
• Competitive trial landscape

These insights enable sponsors to develop realistic enrollment forecasts and risk-adjusted recruitment plans, aligning with USFDA and EMA expectations for study execution.

Key Elements of a Targeted Recruitment Strategy

1. Data-Driven Site Selection

Use historical and feasibility data to select high-performing sites. Key metrics include:

• Previous enrollment performance (patients/month)
• Screen failure rates
• Protocol deviation history
• Demographic alignment with study population

Cross-reference feasibility feedback with central databases and sponsor-maintained KPIs to refine site selection.

2. Enrollment Forecasting and Modeling

After site selection, develop predictive models to estimate potential recruitment. These models should account for:

• Site-specific enrollment rate
• Estimated screen failure and dropout rates
• Lag time from activation to first patient in (FPI)
• Competition from overlapping trials

Forecasts help set expectations and allocate recruitment resources effectively.

3. Site-Level Recruitment Planning

Each site should have a tailored recruitment plan based on feasibility findings. Include:

• Patient identification strategies (EHRs, registries, referrals)
• Outreach channels (community engagement, social media, advocacy groups)
• Recruitment materials approved by IRB/EC
• Dedicated site staff and recruitment coordinators

4. Centralized Recruitment Support

Offer centralized tools to supplement site efforts:

• Pre-screening platforms
• Digital advertising campaigns
• Call centers for eligibility screening
• Logistical support for patient travel or reimbursements

Coordination between site and sponsor is essential for execution, especially in trials requiring specialized Stability Studies.

How to Translate Feasibility into Action

Step 1: Collect and Standardize Feasibility Data

Use structured feasibility questionnaires that include both quantitative metrics and qualitative inputs. Ensure standardization across sites for fair comparison.

Step 2: Score and Rank Sites

Develop a scoring system that weighs factors such as:

• Patient availability (40%)
• Investigator motivation (20%)
• Infrastructure readiness (15%)
• Recruitment plan robustness (25%)

This helps in ranking and selecting sites strategically.

Step 3: Customize Recruitment Targets

Set site-specific enrollment goals based on feasibility outcomes. Avoid flat target distribution—adjust based on each site’s potential.

Step 4: Align Resources with Performance

Allocate recruitment support budgets in proportion to expected enrollment. Sites with lower patient volume may need more sponsor support or may not be activated at all.

Regulatory Considerations for Recruitment Planning

Recruitment strategies must comply with GCP and IRB/EC expectations. This includes:

• Approved recruitment materials and advertisements
• Informed consent procedures embedded into outreach
• Equitable participant selection avoiding coercion or bias

Agencies like Health Canada and SFDA (China) review enrollment feasibility in clinical trial applications.

Sample Feasibility Summary Template

Best Practices for Recruitment Planning

1. Conduct site feasibility early—at protocol design stage
2. Use centralized tools to manage feasibility data (e.g., FeRMI, TRIAD)
3. Integrate feasibility into protocol feasibility and scenario planning
4. Share findings with sites transparently to align expectations
5. Update recruitment strategies during interim reviews based on performance

Leveraging SOPs and Training

Use Pharma SOPs to define processes for feasibility review, site activation decisions, and ongoing recruitment performance tracking. Training staff on feasibility interpretation is critical to informed decision-making.

Conclusion: From Feasibility to First Patient In

A targeted recruitment strategy begins with understanding site capabilities and patient availability. Feasibility assessments provide a blueprint for customizing enrollment plans that are realistic, data-driven, and site-specific. By grounding recruitment in feasibility, sponsors can accelerate timelines, improve trial efficiency, and meet regulatory expectations with confidence.